Cost-effectiveness of mobile clinic screening services for diabetes retinopathy management in Singapore
Care Continuum
Care Process & Redesign
Technology
ACE Value-Based Healthcare Conference
Agency for Integrated Care - Intermediate and Long Term Care
SingHealth
31 December 2024
Determine the incremental cost-effectiveness of mobile clinic AI-based diabetic retinopathy screening compared to primary. Mobile AI screening models are cost-effective and beneficial for large-scale diabetic retinopathy prevention.
Year Submitted: 2024
Published Date: 31 December 2024
Tags: Technology, Care Process ＆ Redesign, Care Continuum, Digital Health, Telehealth, Mobile Health, Productivity, Cost Saving, Access To Care, Waiting Time, Chronic Care, Primary Care, Preventive Care, Community Health
About this Content
Aims
Determine the incremental cost-effectiveness of mobile clinic AI-based diabetic retinopathy screening compared to primary care-based assessment in Singapore.
Background
Diabetic retinopathy (DR) is a leading cause of blindness. AI-driven mobile clinic screening has been introduced as an alternative to traditional primary care-based DR assessments.
Methods
A hybrid decision tree/Markov model was used to compare costs, effectiveness, and incremental cost-effectiveness ratio (ICER) of mobile clinics versus primary care screening over a lifetime horizon.
Results
From a societal perspective, mobile screening reduced costs by S$515 per patient while maintaining similar QALYs. Extrapolated to 170,000 yearly screenings, potential cost savings of S$15 billion over a lifetime were estimated.
Conclusion
Mobile AI screening models are cost-effective and beneficial for large-scale diabetic retinopathy prevention. Further policy integration can optimize resource allocation.
Lessons Learnt
AI-driven mobile clinics enhance primary healthcare, reduce hospital strain, and improve preventive care. Cost-effectiveness data can inform policymaking.
Keywords
Diabetes, Telemedicine, Mobile Clinic, Diabetic Retinopathy Screening, Cost Effectiveness
Innovators' Details
Innovators' Details
Healthcare Cluster(s) | SingHealth, Agency for Integrated Care - Intermediate and Long Term Care |
Organization(s) Involved | Republic Polytechnic, Singapore National Eye Centre, DUKE - University National University of Singapore, London School of Economics, Diabetes SG |
Platform(s) | ACE Value-Based Healthcare Conference |
Healthcare Professional Group(s) | Ancillary Care |
Applicable Specialty or Discipline | Ophthalmology, Endocrinology |
Project Lead(s) | Chaitra Jagdish |
Project Member(s) | Prof. Charumathi Sabanayagam |
Connect with this contributor!
Chaitra Jagdish - Chaitra_jagdish@rp.edu.sg